trading

Based on my years of investing andBioTech's, I believe the post below is legit, as it correctly lays out the pre-EUA application process, along with the clarification of the process of filing to first receive FDA authorization for professional use only, as the in-home test will take a bit longer to receive an EUA. I found the post to be very logical and well thought out - overall, a VERY good analysis of the current state and timeline for receiving an EUA from the FDA.To clear up any confusion for Longs and interested Investors....I'd like to discuss my phone call with the FDA office regarding Diagnostic Test Kits for Covid19 but first let me clear up some of the progress that has been being made over the last month....On April 6th DECN announces they received notification of Acceptance from FDA on April 4th for their Swift Kit Pro Version for Hospitals and Professionals.On April 7th they announced they received PRE EUA Acknowledgment Letterand Product Serial Number PEUA200232 for the (Professional Use) and thatthe Application for the (Home Use) device is in process as well.Today they announced that next week they will be asking the FDA to grant them a conditional but immediate EUA approval subject only to testing so that they can move quicker rather than procded with the PRE EUA designation. This is key to understand, if the FDA grants this"conditinal but immediate EUA approval" it will be huge for thecompany and the stock price, if not, then it will have to go through the regular process of the PRE EUA designation. We will find that out sometime next week it seems. This once again is for the (Professional Use) product, not the (Home Use)They also announced today that they will be filing soon with the FDA forEUA for the (Home Use) product very soon. I would also expect to hearabout this either tomorrow or sometime next week, which should give usmore information that things are moving along.They also in earlier PR explained why they filed these two different products (one for Professional and one for Home use) at different times, which is because the FDA had "yet to approve a kit designed for individual use, we decided to proceed first with the Pro version Swift kit and follow on as soon as possible with a separate EUA application for the at-home kit as a stand-alone application. We plan to use the same application with minor changes to reflect the individual use."This tells me that they are moving very strategically. Once again, in today's PR they explain that they realized in early April that it was not a good idea yet to apply for both but on April 21st the Government changed their minds about (at Home use) and that opened the door for DECN to start moving on applying for this segment as well.... see below"Our original plan for GenViro! was to offer a single kit containing two PFUs (user's guide), one for Professional Use, one for at-home individual use. Otherwise, the contents of the kits were identical --- 3-test strips, 5-lancets, 1-check strip. However, as March moved into April it became clear that the FDA was not approving individual at-home use kits. So in order to move its application along within the EUA review system, DECN removed all of the description and data owing to the individual at-home kit. And now we bring it back -- by demand."On April 21, 2020 the FDA approved an at-home sample collection device for Covid-19 testing, allowing individuals to purchase the collection kits, collect their own samples and then use the mails or other package service to deliver the sample to a laboratory for assay. Oftentimes government moves slowly, but they also tend to build large doors and then open them. DECN views this as an opportunity to become the first company to provide an all-in-one, immediate result, individual at-home Covid-19 test kits with its GenViro! Swift kit for at-home use. We intend to file our stand-alone EUA application for the individual use GenViro! Swift kit by May 1."So this is big news as well, we will be informed that they have applied for the (at Home use) product by May 1st. Lots of news next week coming!Now finally my discussion with the lady from the FDA... I called her because I wanted to verify the PEUA Serial number with the company to know that all this was moving forward. What she told me is that ifa company is in the PRE EUA stage and has the PEAU200--- figure that means they are not listed yet on the FDA website. Only after they are accepted (which as after they have submitted everything neededfor review including "testing results") will they move it to EUA and then the company will be listed on the FDA website under the Diagnostic Kits for Covid19 being applied for. Remember that next week DECNis going to try to bypass all of this for "Conditional but Immediate" use. We will either get lucky here or we won't. I think if we have a good product we may get this granted which would pretty much solidifythe company and it's product. This can pretty much put all the bashing to sleep next week.The lady told me that the EUA process could take 2-3 weeks if it is accepted from the PEUA process. So everything that I have read and talked about with the lady from the FDA makes complete sense. I know the PR's have been a little confusing, but once you sit and read through them one by one you realize that everything is moving along correctly and at a fast pace.